FrancophonIA/ELRC3.0 huggingface dataset:
English: What NovoMix 50 is and what it is used for
Estonian: Mis ravim on NovoMix 50 ja milleks seda kasutatakse
English: Important information about some of the ingredients in NovoMix 50
Estonian: Oluline teave mõningate NovoMix 50 koostisainete suhtes
English: In clinical trials, the frequency of hypoglycaemia varied with patient population, dose regimens and level of glycaemic control.
Estonian: Kliinilistes uuringutes hüpoglükeemia sagedus varieerub koos patsiendipopulatsiooni,
English: Lipodystrophy:
Estonian: Lipodüstroofia:
English: What NovoMix 70 is and what it is used for What you need to know before you use NovoMix 70 How to use NovoMix 70
Estonian: Mis ravim on NovoMix 70 ja milleks seda kasutatakse Mida on vaja teada enne NovoMix 70 kasutamist Kuidas NovoMix 70 kasutada Võimalikud kõrvaltoimed
English: Your blood sugar level may fall (hypoglycaemia) if you take:
Estonian: Teie veresuhkru tase võib langeda (hüpoglükeemia), kui kasutate:
English: • If the second and third characters are S6, P5, K7, R7, VG, FG or ZF, the manufacturer is Novo Nordisk A/S, Novo Allé, DK-2880 Bagsværd, Denmark.
Estonian: Tootja saab kindlaks teha partii numbri järgi pakendil ja etiketil: - Kui teine ja kolmas kirjamärk on S6, P5, K7, R7, VG, FG või ZF, on tootjaks Novo Nordisk
English: The influence of different injection sites on the absorption of NovoMix 70 has not been investigated.
Estonian: Erinevate süstekohtade mõju NovoMix 70 imendumisele ei ole uuritud.
English: NovoMix 70 is a biphasic insulin, which contains 70% soluble insulin aspart.
Estonian: NovoMix 70 on bifaasiline insuliin, mis sisaldab 70% lahustuvat aspartinsuliini.
English: NovoMix 30 contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoMix 30 is essentially ‘sodium-free'.
Estonian: NovoMix 30 sisaldab vähem kui 1 mmol naatriumi (23 mg) annuse kohta, st NovoMix 30 on sisuliselt naatriumivaba.
English: EU/1/00/142/023 1 pen of 3 ml EU/1/00/142/009 5 pens of 3 ml EU/1/00/142/010 10 pens of 3 ml EU/1/00/142/024 1 pen of 3 ml and 7 NovoFine needles EU/1/00/142/025 1 pen of 3 ml and 7 NovoTwist needles
Estonian: EU/1/00/142/023 1 pen-süstel x 3 ml EU/1/00/142/009 5 pen-süstlit x 3 ml EU/1/00/142/010 10 pen-süstlit x 3 ml EU/1/00/142/024 1 pen-süstel x 3 ml ja 7 nõela NovoFine EU/1/00/142/025 1 pen-süstel x 3 ml ja 7 nõela NovoTwist
English: NovoMix 70 is not to be used in insulin infusion pumps.
Estonian: NovoMix 70 ei tohi kasutada insuliinipumpades.
English: Before using NovoMix 70
Estonian: Enne NovoMix 70 kasutamist
English: NovoMix 70 Penfill and NovoMix 70 FlexPen:
Estonian: NovoMix 70 Penfill ja NovoMix 70 FlexPen:
English: Prior to each injection, small amounts of air may collect in the cartridge during normal use.
Estonian: Tavapärasel kasutamisel võib kolbampulli sattuda väike kogus õhku.
English: The influence of different injection sites on the absorption of NovoMix 50 has not been investigated.
Estonian: Erinevate süstekohtade mõju NovoMix 50 imendumisele ei ole uuritud.
English: NovoMix 70 contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoMix 70 is essentially ‘sodium-free'.
Estonian: NovoMix 70 sisaldab vähem kui 1 mmol naatriumi (23 mg) annuse kohta, st NovoMix 70 on sisuliselt naatriumivaba.
English: This has a rapid onset of action, thus allowing it to be given closer to a meal (within zero to 10 minutes of the meal) when compared to soluble human insulin.
Estonian: Võrreldes lahustuva humaaninsuliiniga algab selle toime kiiresti, võimaldades manustamist vahetult enne sööki või 0...10 minuti jooksul pärast söömise alustamist.
English: NovoMix 50 must not be administered intravenously, as it may result in severe hypoglycaemia.
Estonian: NovoMix 50 ei tohi manustada intravenoosselt, sest see võib põhjustada rasket hüpoglükeemiat.
English: NovoMix 70 must not be administered intravenously, as it may result in severe hypoglycaemia.
Estonian: NovoMix 70 ei tohi manustada intravenoosselt, sest see võib põhjustada rasket hüpoglükeemiat.
English: • The other ingredients are glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, protamine sulfate, hydrochloric acid, sodium hydroxide and water for injections.
Estonian: • Abiained on glütserool, fenool, metakresool, tsinkkloriid, dinaatriumfosfaatdihüdraat, naatriumkloriid, protamiinsulfaat, vesinikkloriidhape, naatriumhüdroksiid ja süstevesi.
English: What NovoMix 50 is and what it is used for What you need to know before you use NovoMix 50 How to use NovoMix 50
Estonian: Mis ravim on NovoMix 50 ja milleks seda kasutatakse Mida on vaja teada enne NovoMix 50 kasutamist Kuidas NovoMix 50 kasutada Võimalikud kõrvaltoimed
English: NovoMix 50 is not to be used in insulin infusion pumps.
Estonian: NovoMix 50 ei tohi kasutada insuliinipumpades.
English: Before travelling between different time zones, the patient should seek the doctor's advice since this may mean that the patient has to take the insulin and meals at different times.
Estonian: Reisimine eri ajavööndites võib tähendada ka erinevaid aegu insuliini süstimiseks ja söömiseks, seepärast tuleks enne teele asumist arstiga nõu pidada.
English: There is limited clinical experience with NovoMix 70 in pregnancy.
Estonian: NovoMix 70 kasutamise kliiniline kogemus raseduse ajal on piiratud.
English: Since NovoMix 50 should be administered in immediate relation to a meal, the rapid onset of action should be considered in patients with concomitant diseases or treatment where a delayed absorption of food might be expected.
Estonian: Kuna NovoMix 50 peab manustama otseses vastavuses söögikordadega, siis tuleks kaaluda kiire toimealguse vajalikkust juhul, kui kaasnev haigus või ravi võib söögi imendumist pidurdada.
English: • Move the delivery system with the cartridge inside up and down between a and b (see picture B) at least 10 times until the liquid appears uniformly white, cloudy and aqueous.
Estonian: • Liigutage süstevahendit koos kolbampulliga asendite a ja b vahel (vaata joonis B) üles-alla vähemalt 10 korda, kuni vesisuspensioon on ühtlaselt valge ja hägune.
English: Continuous rotation of the injection site within the particular area reduces the risk of developing these reactions.
Estonian: Süstekoha pidev vahetamine ka sama piirkonna ulatuses vähendab nende reaktsioonide tekkeriski.
English: What you need to know before you use NovoMix 70
Estonian: Mida on vaja teada enne NovoMix 70 kasutamist
English: What NovoMix 70 looks like and contents of the pack
Estonian: Kuidas NovoMix 70 välja näeb ja pakendi sisu
English: After removing NovoMix 50 Penfill or NovoMix 50 FlexPen from the refrigerator, it is recommended to allow NovoMix 50 Penfill or NovoMix 50 FlexPen to reach room temperature before resuspending the insulin as instructed for first time use.
Estonian: Soovitav on lasta külmkapist võetud NovoMix 50 Penfill'il või NovoMix 50 FlexPen'il saavutada toatemperatuur enne resuspendeerimist vastavalt esmakordse kasutamise juhistele.
English: However, the NovoMix 30 dose may need to be adjusted.
Estonian: Küll aga võib tekkida vajadus korrigeerida NovoMix 30 annust.
English: Before using NovoMix 50
Estonian: Enne NovoMix 50 kasutamist
English: NovoMix 50 is used to reduce the high blood sugar level in patients with diabetes mellitus (diabetes).
Estonian: NovoMix 50 kasutatakse veresuhkru alandamiseks suhkurtõbe (diabeeti) põdevatel patsientidel.
English: Hypoglycaemia:
Estonian: Hüpoglükeemia:
English: After removing NovoMix 70 Penfill or NovoMix 70 FlexPen from the refrigerator, it is recommended to allow NovoMix 70 Penfill or NovoMix 70 FlexPen to reach room temperature before resuspending the insulin as instructed for first time use.
Estonian: Soovitav on lasta külmkapist võetud NovoMix 70 Penfill'il või NovoMix 70 FlexPen'il saavutada toatemperatuur enne resuspendeerimist vastavalt esmakordse kasutamise juhistele.
English: However, the NovoMix 70 dose may need to be adjusted.
Estonian: Küll aga võib tekkida vajadus korrigeerida NovoMix 70 annust.
English: What you need to know before you use NovoMix 50
Estonian: Mida on vaja teada enne NovoMix 50 kasutamist
English: Keep the cartridge in the outer carton in order to protect it from light.
Estonian: Hoida kolbampull välispakendis valguse eest kaitstult.
English: A meta-analysis including nine trials in patients with type 1 and type 2 diabetes showed that fasting blood glucose was higher in patients treated with NovoMix 30, than in patients treated with biphasic human insulin 30.
Estonian: I ja II tüüpi diabeediga patsientide üheksat uuringut hõlmav metaanalüüs näitas, et insuliiniga NovoMix 30 ravitud patsientide paastuglükoos oli kõrgem kui bifaasilist humaaninsuliini 30 saanuil.
English: NovoMix 30 is a biphasic insulin, which contains 30% soluble insulin aspart.
Estonian: NovoMix 30 on bifaasiline insuliin, mis sisaldab 30% lahustuvat aspartinsuliini.
English: ► Every time you use a new NovoMix 50 Penfill (before you put the cartridge into the insulin delivery system)
Estonian: ► Iga kord, kui võtate uue NovoMix 50 Penfill'i (enne kolbampulli asetamist insuliini süstevahendisse)
English: NovoMix 50 is a mixture consisting of 50% soluble insulin aspart and 50% insulin aspart crystallised with protamine.
Estonian: NovoMix 50 on segu, mis koosneb 50% lahustuvast aspartinsuliinist ja 50% protamiiniga kristalliseeritud aspartinsuliinist.
English: No clinical studies with NovoMix 70 have been carried out in children and adolescents under the age of 18 years.
Estonian: Kliinilised uuringud NovoMix 70 alla 18-aastaste laste ja noorukite ravi kohta puuduvad.
English: At the beginning of the insulin treatment, refraction anomalies, oedema and injection site reactions (pain, redness, hives, inflammation, bruising, swelling and itching at the injection site) may occur.
Estonian: Insuliinravi alguses võivad tekkida refraktsioonianomaaliad, turse ja süstekoha reaktsioonid (süstekoha valu, punetus, lööve, põletik, muljumisjäljed, turse ja sügelus).
English: Since NovoMix 30 should be administered in immediate relation to a meal, the rapid onset of action should be considered in patients with concomitant diseases or treatment where a delayed absorption of food might be expected.
Estonian: Kuna NovoMix 30 peab manustama otseses vastavuses söögikordadega, siis tuleks kaaluda kiire toimealguse vajalikkust juhul, kui kaasnev haigus või ravi võib söögi imendumist pidurdada.
English: However, the NovoMix 50 dose may need to be adjusted.
Estonian: Küll aga võib tekkida vajadus korrigeerida NovoMix 50 annust.
English: During clinical trials, the overall rates of hypoglycaemia did not differ between patients treated with insulin aspart compared to human insulin.
Estonian: Kliinilistes uuringutes ei ole leitud erinevusi hüpoglükeemia esinemises aspartinsuliini ja humaaninsuliiniga ravitud patsientidel.
English: If you take too much insulin, your blood sugar gets too low (hypoglycaemia).
Estonian: Kui te süstite liiga palju insuliini, langeb teie veresuhkur väga madalale(hüpoglükeemia).
English: The insulin aspart in the soluble phase of NovoMix 70 comprises 70% of the total insulin; this is absorbed more rapidly from the subcutaneous layer than the soluble insulin component of biphasic human insulin.
Estonian: Lahustuvas faasis olev aspartinsuliin moodustab 70% kogu NovoMix 70 olevast insuliinist: see imendub nahaalusest koest kiiremini kui bifaasilise humaaninsuliini lahustuva insuliini komponent.
English: What NovoMix 50 looks like and contents of the pack
Estonian: Kuidas NovoMix 50 välja näeb ja pakendi sisu
English: In patients with renal or hepatic impairment, glucose monitoring should be intensified and the insulin aspart dose adjusted on an individual basis.
Estonian: Neeru või maksakahjustusega patsientide glükoosimonitooringut tuleb intensiivistada ja aspartinsuliini annust kohandada individuaalselt.
English: Signs of allergy: Local allergic reactions (pain, redness, hives, inflammation, bruising, swelling and itching) at the injection site may occur.
Estonian: Süstekohas võivad tekkida paiksed allergilised reaktsioonid (valu, punetus, lööve, põletik, muljumisjäljed, turse ja sügelus).
English: Do not use this medicinal product if you notice that the resuspended liquid is not uniformly white, cloudy and aqueous.
Estonian: Ärge kasutage seda ravimit, kui resuspendeeritud vesisuspensioon ei ole ühtlaselt valge ja hägune.
English: Always remove the needle after each injection and store your FlexPen without the needle attached.
Estonian: Pärast iga süstimist eemaldage alati nõel ja hoidke FlexPen ilma nõelata.
English: The pharmacokinetics of NovoMix 70 have not been investigated in paediatrics, elderly patients or in patients with renal or hepatic impairment.
Estonian: NovoMix 70 farmakokineetikat ei ole uuritud lastel, eakatel patsientidel ja neeru- või maksafunktsiooni häirega patsientidel.
English: NovoMix 30 must not be administered intravenously, as it may result in severe hypoglycaemia.
Estonian: NovoMix 30 ei tohi manustada intravenoosselt, sest see võib põhjustada rasket hüpoglükeemiat.
English: What NovoMix 30 is and what it is used for
Estonian: Mis ravim on NovoMix 30 ja milleks seda kasutatakse
English: Needle Paper tab
Estonian: Nõel Paberkleebik
English: The safety and efficacy of NovoMix 70 in children below 18 years of age have not been established.
Estonian: NovoMix 70 ohutus ja efektiivsus noorematel kui 18-aastastel lastel ei ole kinnitust leidnud.
English: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting.
Estonian: Keskmise või pika toimeajaga ja lühikese toimeajaga insuliinide ja nende analoogide kombinatsioonid süstimiseks.
English: NovoMix 30 is not to be used in insulin infusion pumps.
Estonian: NovoMix 30 ei tohi kasutada insuliinipumpades.
English: NovoMix 50 is a biphasic insulin, which contains 50% soluble insulin aspart.
Estonian: NovoMix 50 on bifaasiline insuliin, mis sisaldab 50% lahustuvat aspartinsuliini.
English: There is limited clinical experience with NovoMix 50 in pregnancy.
Estonian: NovoMix 50 kasutamise kliiniline kogemus raseduse ajal on piiratud.
English: NovoMix 70 is used to reduce the high blood sugar level in patients with diabetes mellitus (diabetes).
Estonian: NovoMix 70 kasutatakse veresuhkru alandamiseks suhkurtõbe (diabeeti) põdevatel patsientidel.
English: Before using NovoMix 30
Estonian: Enne NovoMix 30 kasutamist
English: NovoMix 30 Penfill and NovoMix 30 FlexPen:
Estonian: NovoMix 30 Penfill ja NovoMix 30 FlexPen:
English: There is limited clinical experience with NovoMix 30 in pregnancy.
Estonian: NovoMix 30 kasutamise kliiniline kogemus raseduse ajal on piiratud.
English: See Resuspension of NovoMix 70 in section 3.
Estonian: Vaata NovoMix 70 resuspendeerimine lõigus 3 Kuidas kasutada NovoMix 70.
English: The influence of different injection sites on the absorption of NovoMix 30 has not been investigated.
Estonian: Erinevate süstekohtade mõju NovoMix 30 imendumisele ei ole uuritud.
English: LIST OF EXCIPIENTS glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, protamine sulfate, hydrochloric acid/sodium hydroxide for pH adjustment and water for injections
Estonian: ABIAINED glütserooli, fenooli, metakresooli, tsinkkloriidi, dinaatriumfosfaatdihüdraati, naatriumkloriidi, protamiinsulfaati, vesinikkloriidhapet/naatriumhüdroksiidi pH reguleerimiseks ja süstevett.
English: Since NovoMix 70 should be administered in immediate relation to a meal, the rapid onset of action should be considered in patients with concomitant diseases or treatment where a delayed absorption of food might be expected.
Estonian: Kuna NovoMix 70 peab manustama otseses vastavuses söögikordadega, siis tuleks kaaluda kiire toimealguse vajalikkust juhul, kui kaasnev haigus või ravi teiste preparaatidega võib söögi imendumist pidurdada.
English: ► Every time you use a new NovoMix 30 Penfill (before you put the cartridge into the insulin delivery system)
Estonian: ► Iga kord, kui võtate uue NovoMix 30 Penfill'i (enne kolbampulli asetamist insuliini süstevahendisse)
English: The necessity of resuspending the NovoMix 70 suspension immediately before use is to be stressed to the patient.
Estonian: Patsiendile tuleb rõhutada vajadust resuspendeerida NovoMix 70 suspensioon vahetult enne kasutamist.
English: Serious allergic reactions to NovoMix 70 or one of its ingredients (called a systemic allergic reaction) is a very rare side effect, but it can potentially be life-threatening.
Estonian: Tõsine allergiline reaktsioon NovoMix 70 või mõne selle koostises oleva aine suhtes (nimetatakse süsteemseks allergiliseks reaktsiooniks).
English: ► If you are allergic to insulin aspart or any of the other ingredients in this medicine (see section
Estonian: ► kui olete aspartinsuliini või mis tahes koostisosade (loetletud lõigus 6 Pakendi sisu ja muu teave) suhtes allergiline.
English: In a 3 month trial in patients with type 1 and type 2 diabetes, NovoMix 30 showed equal control of glycosylated haemoglobin compared to treatment with biphasic human insulin 30.
Estonian: Kolm kuud väldanud uuringus, milles osalesid I ja II tüüpi diabeediga patsiendid, tagas NovoMix 30 samaväärse glükosüleerunud hemoglobiini taseme kui bifaasiline humaaninsuliin 30.
English: When necessary, NovoMix 70 can be given soon after a meal.
Estonian: Vajadusel võib NovoMix 70 manustada varsti pärast sööki.
English: The insulin aspart in the soluble phase of NovoMix 50 comprises 50% of the total insulin; this is absorbed more rapidly from the subcutaneous layer than the soluble insulin component of biphasic human insulin.
Estonian: Lahustuvas faasis olev aspartinsuliin moodustab 50% kogu NovoMix 50 olevast insuliinist: see imendub nahaalusest koest kiiremini kui bifaasilise humaaninsuliini lahustuva insuliini komponent.
English: What NovoMix 30 is and what it is used for What you need to know before you use NovoMix 30 How to use NovoMix 30
Estonian: Mis ravim on NovoMix 30 ja milleks seda kasutatakse Mida on vaja teada enne NovoMix 30 kasutamist Kuidas NovoMix 30 kasutada Võimalikud kõrvaltoimed
English: NovoMix 50 Penfill and NovoMix 50 FlexPen:
Estonian: NovoMix 50 Penfill ja NovoMix 50 FlexPen:
English: No clinical studies with NovoMix 50 have been carried out in children and adolescents under the age of 18 years.
Estonian: Kliinilised uuringud NovoMix 50 alla 18-aastaste laste ja noorukite ravi kohta puuduvad.
English: On rare occasions, injection site reactions may require discontinuation of NovoMix 70.
Estonian: Harvadel juhtudel nõuavad süstekoha reaktsioonid NovoMix 70 ravi lõpetamist.
English: The safety and efficacy of NovoMix 50 in children below 18 years of age have not been established.
Estonian: NovoMix 50 ohutus ja efektiivsus noorematel kui 18-aastastel lastel ei ole kinnitust leidnud.
English: NovoMix 50 is a biphasic suspension of 50% soluble insulin aspart (rapid-acting human insulin analogue) and 50% protamine-crystallised insulin aspart (intermediate-acting human insulin analogue).
Estonian: NovoMix 50 on 50% lahustuva aspartinsuliini (kiiretoimelise humaaninsuliini analoog) ja 50% protamiiniga kristalliseeritud aspartinsuliini (keskmise toimeajaga humaaninsuliini analoog) bifaasiline suspensioon.
English: • No data are available for NovoMix 30 in children below 6 years of age.
Estonian: • Andmed puuduvad NovoMix 30 kasutamise kohta noorematel kui 6-aastastel lastel.
English: See Resuspension of NovoMix 50 in section 3.
Estonian: Vaata NovoMix 50 resuspendeerimine lõigus 3 Kuidas kasutada NovoMix 50.
English: In patients with type 2 diabetes, NovoMix 70 can be given as monotherapy or in combination with metformin when the blood glucose is inadequately controlled with metformin alone.
Estonian: NovoMix 70 võib selle vajaduse täielikult või osaliselt katta II tüüpi diabeediga patsientidele võib NovoMix 70 manustada kas monoteraapiana või kombinatsioonis metformiiniga, kui metformiin üksi ei taga vere glükoosisisalduse piisavat kontrolli.
English: In healthy volunteers, a mean maximum serum concentration of 140 ± 32 pmol/l was reached about 60 minutes after a subcutaneous dose of 0.20 unit/kg body weight.
Estonian: Tervetel vabatahtlikel saabus keskmine maksimaalne seerumikontsentratsioon (140 ± 32 pmol/l) umbes 60 minutit pärast subkutaanse annuse 0,20 ühikut/kehakaalu kg kohta manustamist.
English: See Resuspension of NovoMix 30 in section 3.
Estonian: Vaata NovoMix 30 resuspendeerimine lõigus 3 Kuidas kasutada NovoMix 30.
English: There is limited clinical experience with insulin aspart in pregnancy.
Estonian: Aspartinsuliini rasedusaegse kasutamise kliinilise kogemuse kohta on piiratud andmed.
English: ► Every time you use a new NovoMix 70 Penfill (before you put the cartridge into the insulin delivery system)
Estonian: ► Iga kord, kui võtate uue NovoMix 70 Penfill'i (enne kolbampulli asetamist insuliini süstevahendisse).
English: When necessary, NovoMix 50 can be given soon after a meal.
Estonian: Vajadusel võib NovoMix 50 manustada varsti pärast sööki.
English: What you need to know before you use NovoMix 30
Estonian: Mida on vaja teada enne NovoMix 30 kasutamist
English: The insulin aspart in the soluble phase of NovoMix 30 comprises 30% of the total insulin; this is absorbed more rapidly from the subcutaneous layer than the soluble insulin component of biphasic human insulin.
Estonian: Lahustuvas faasis olev aspartinsuliin moodustab 30% kogu NovoMix 30 olevast insuliinist: see imendub nahaalusest koest kiiremini kui bifaasilise humaaninsuliini lahustuva insuliini komponent.
English: What NovoMix 30 looks like and contents of the pack
Estonian: Kuidas NovoMix 30 välja näeb ja pakendi sisu
English: Resuspension of NovoMix 30
Estonian: NovoMix 30 resuspendeerimine
English: The pharmacokinetics of NovoMix 50 have not been investigated in paediatrics, elderly patients or in patients with renal or hepatic impairment.
Estonian: NovoMix 50 farmakokineetikat ei ole uuritud lastel, eakatel patsientidel ja neeru- või maksafunktsiooni häirega patsientidel.
English: Before your first injection with a new FlexPen, you must resuspend the insulin: Roll the pen between your palms 10 times - it is important that the pen is kept horizontal (level with the ground).
Estonian: Rullige süstevahendit peopesade vahel 10 korda - oluline on hoida vahendit horisontaalselt (maapinnaga paralleelselt).
English: 4.2, the mean reduction in HbA1c was 2.8% with NovoMix 30 (mean at baseline = 9.7%).
Estonian: Pärast 28 nädalat väldanud ravi lõigus 4.2 esitatud annustamisskeemi kohaselt vähenes NovoMix 30 ravitute HbA1C keskmiselt 2,8% (algväärtuste keskmine 9,7%).
English: Limited clinical data exists for children aged 6-9 years.
Estonian: 6…9-aastaste laste ravi kohta on kliinilised andmed piiratud.
English: A 16-week clinical trial comparing postprandial glycaemic control of meal-related NovoMix 30 with meal-related human insulin/biphasic human insulin 30 and bedtime NPH insulin was performed in 167 patients aged 10 to 18 years.
Estonian: Söögikorraga seotud NovoMix 30-ga saavutatavat postprandiaalset glükeemilist kontrolli võrreldi söögikorraga seotud humaaninsuliini/bifaasilise humaaninsuliini 30 ja enne magamaminekut manustatava NPHinsuliini puhul saavutatavaga.
English: Serious allergic reactions to NovoMix 50 or one of its ingredients (called a systemic allergic reaction) is a very rare side effect, but it can potentially be life-threatening.
Estonian: Tõsine allergiline reaktsioon NovoMix 50 või mõne selle koostises oleva aine suhtes (nimetatakse süsteemseks allergiliseks reaktsiooniks).
English: NovoMix 50 FlexPen is a pre-filled, colour-coded, disposable pen containing a mixture of rapid-acting and intermediate-acting insulin aspart in the ratio 50/50.
Estonian: NovoMix 50 FlexPen on värviga märgistatud, eeltäidetud, ühekordseks kasutamiseks mõeldud pensüstel, mis sisaldab kiiretoimelise ja keskmise toimeajaga aspartinsuliini segu vahekorras 50/50.
English: If any of these apply, do not use NovoMix 70.
Estonian: Ülaltoodud juhtudel ärge NovoMix 70 kasutage.
English: ► If you are treated with NovoMix 70 Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin.
Estonian: ► Kui kasutate üheaegselt NovoMix 70 Penfill'i ja mõne teise insuliini Penfill-kolbampulli, peate kasutama kummagi insuliinitüübi jaoks eraldi süstevahendit.